The route to solve the interplay between inflammation, angiogenesis and anti-cancer immune response

Phase I trial of thymidylate synthase poly-epitope peptide (TSPP) vaccine in advanced cancer patients

(2015) Maria Grazia Cusi et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Phase Ib study of poly-epitope peptide vaccination to thymidylate synthase (TSPP) and GOLFIG chemo-immunotherapy for treatment of metastatic colorectal cancer patients

(2015) Pierpaolo Correale et al.   OncoImmunology

Myeloid-Derived Suppressor Cells in Multiple Myeloma: Pre-Clinical Research and Translational Opportunities

(2014) Cirino Botta et al.   Frontiers in Oncology

Control of the Immune Response by Pro-Angiogenic Factors

(2014) Thibault Voron et al.   Frontiers in Oncology

Systemic inflammatory status at baseline predicts bevacizumab benefit in advanced non-small cell lung cancer patients

(2013) Cirino Botta et al.   CANCER BIOLOGY & THERAPY

Gemcitabine, Oxaliplatin, Levofolinate, 5-Fluorouracil, Granulocyte-Macrophage Colony-Stimulating Factor, and Interleukin-2 (GOLFIG) Versus FOLFOX Chemotherapy in Metastatic Colorectal Cancer Patients

(2013) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY

Tumor infiltration by chemokine receptor 7 (CCR7)+T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer

(2012) Pierpaolo Correale et al.   OncoImmunology

Phase II trial of bevacizumab and dose/dense chemotherapy with cisplatin and metronomic daily oral etoposide in advanced non-small-cell-lung cancer patients

(2011) Pierpaolo Correale et al.   CANCER BIOLOGY & THERAPY

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Tumor Infiltration by T Lymphocytes Expressing Chemokine Receptor 7 (CCR7) Is Predictive of Favorable Outcome in Patients with Advanced Colorectal Carcinoma

(2011) P. Correale et al.   CLINICAL CANCER RESEARCH

Dose/dense metronomic chemotherapy with fractioned cisplatin and oral daily etoposide enhances the anti-angiogenic effects of bevacizumab in advanced non-small-cell-lung cancer patients

(2010) Pierpaolo Correale et al.   CANCER BIOLOGY & THERAPY

Regulatory (FoxP3+) T-cell Tumor Infiltration Is a Favorable Prognostic Factor in Advanced Colon Cancer Patients Undergoing Chemo or Chemoimmunotherapy

(2010) Pierpaolo Correale et al.   JOURNAL OF IMMUNOTHERAPY